This study reports the treatment feasibility and efficacy of a novel multiagent intensive treatment program for young patients with desmoplastic small round cell tumor. This small series includes three patients and should be seen as a first suggestion of integration of the dose density and the maintenance chemotherapy concept. The IrIVA regimen (irinotecan, ifosfamide, vincristine, and actinomycin-D) is added—used at a short interval between chemotherapy administrations—at more classic intensive ifosfamide–based regimens. The vinorelbine and low-dose oral cyclophosphamide maintenance therapy is added at the end of conventional chemotherapy to achieve an antiangiogenic effect.
KushnerBHLaQuagliaMPWollnerN, et al. Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy. J Clin Oncol1996; 14: 1526–1531.
2.
ScheerMVokuhlCBlankB, et al. Desmoplastic small round cell tumors: multimodality treatment and new risk factors. Cancer Med2019; 8: 527–542.
3.
HonoréCAmrounKVilcotL, et al. Abdominal desmoplastic small round cell tumor: multimodal treatment combining chemotherapy, surgery, and radiotherapy is the best option. Ann Surg Oncol2015; 22: 1073–1079.
4.
LalDRSuWTWoldenSL, et al. Results of multimodal treatment for desmoplastic small round cell tumors. J Pediatr Surg2005; 40: 251–255.
5.
SaabRKhouryJDKrasinM, et al. Desmoplastic small round cell tumor in childhood: the St Jude Children’s Research Hospital experience. Pediatr Blood Cancer2007; 49: 274–279.
6.
Hayes-JordanAGreenHLLinH, et al. Complete cytoreduction and HIPEC improves survival in desmoplastic small round cell tumor. Ann Surg Oncol2014; 21: 220–224.
7.
MsikaSGrudenESarnackiS, et al. Cytoreductive surgery associated to hyperthermic intraperitoneal chemoperfusion for desmoplastic round small cell tumor with peritoneal carcinomatosis in young patients. J Pediatr Surg2010; 45: 1617–1621.
8.
HonoréCAtallahVMirO, et al. Abdominal desmoplastic small round cell tumor without extraperitoneal metastases: is there a benefit for HIPEC after macroscopically complete cytoreductive surgery?PLoS One2017; 12: e0171639.
9.
BisognoGFerrariARosolenA, et al. Sequential intensified chemotherapy with stem cell rescue for children and adolescents with desmoplastic small round-cell tumor. Bone Marrow Transpl2010; 45: 907–911.
10.
DesaiNBSteinNFLaQuagliaMP, et al. Reduced toxicity with intensity modulated radiation therapy (IMRT) for desmoplastic small round cell tumor (DSRCT): an update on the whole abdominopelvic radiation therapy (WAP-RT) experience. Int J Radiat Oncol Biol Phys2013; 85: e67–e72.
11.
ItalianoAKindMCioffiA, et al. Clinical activity of sunitinib in patients with advanced desmoplastic round cell tumor: a case series. Target Oncol2013; 8: 211–213.
12.
FrezzaABensonCJudsonI, et al. Pazopanib in advanced desmoplastic small round cell tumours: a multi-institutional experience. Clin Sarcoma Res2014; 4: 7.
13.
LiuKXCollinsNBGreenzangKA, et al. The use of interval-compressed chemotherapy with the addition of vincristine, irinotecan, and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumor. Pediatr Blood Cancer2020; 67: e28559.
14.
BisognoGFerrariATagarelliA, et al. Integrating Irinotecan in standard chemotherapy: a novel dose density combination for high-risk pediatric sarcomas. Pediatr Blood Cancer (in press 2021).
15.
BisognoGDe SalvoGLBergeronC, et al. Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol2019; 20: 1566–1575.
16.
PinnixCCFontanillaHPHayes-JordanA, et al. Whole abdominopelvic intensity-modulated radiation therapy for desmoplastic small round cell tumor after surgery. Int J Radiat Oncol Biol Phys2012; 83: 317–326.
17.
TherassePArbuckSGEisenhauerEA, et al. New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst2000; 92: 205–216.
18.
RosoffPMBayliffS.Successful clinical response to irinotecan in desmoplastic round blue cell tumor. Med Pediatr Oncol1999; 33: 500–503.
19.
FerrariAGaspariniPCasanovaM. A “Home run” for rhabdomyosarcoma after 30 years: what now?Tumori2020; 106: 5–11.
20.
FerrariAGrossoFStacchiottiS, et al. Response to vinorelbine and low-dose cyclophosphamide chemotherapy in two patients with desmoplastic small round cell tumor. Ped Blood Cancer2007; 49: 864–866.
